Endocytosis deficiency of epidermal growth factor (EGF) receptor-ErbB2 heterodimers in response to EGF stimulation

Molecular Biology of the Cell

Volumn 10, Issue 5, 1999, Pages 1621-1636

  Wang, Zhixiang ^a   Zhang, Lianfeng ^a   Yeung, Tai K ^a   Chen, Xinmei ^a  

^a UNIVERSITY OF OTTAWA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; EPIDERMAL GROWTH FACTOR RECEPTOR;

ARTICLE; BREAST CANCER; CANCER CELL; CELL FRACTIONATION; CELL PROLIFERATION; DIMERIZATION; ENDOCYTOSIS; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; PRIORITY JOURNAL;

EID: 0032948524     PISSN: 10591524     EISSN: None     Source Type: Journal    
DOI: 10.1091/mbc.10.5.1621     Document Type: Article

References (65)

1. Anders, R.A., Arline, S.L., Dore, J.J., and Leof, E.B. (1997). Distinct endocytic responses of heteromeric and homomeric transforming growth factor beta receptors. Mol. Biol. Cell 8, 2133-2143.
2. Anderson, D., Koch, C.A., Gray, L., Ellis, C., Moran, M.F., and Pawson, T. (1990). Binding of SH2 domains of phospholipase C gamma 1, GAP, and Src to activated growth factor receptors. Science 250, 979-982.
3. Bargmann, C.I., Hung, M.C., and Weinberg, R.A. (1986). Multiple independent activations of the neu oncogene by a point mutation altering the transmembrane domain of p185. Cell 45, 649-657.
4. Baulida, J., Kraus, M.H., Alimandi, M., Di Fiore, P.P., and Carpenter, G. (1996). All ErbB receptors other than the epidermal growth factor receptor are endocytosis impaired. J. Biol. Chem. 271, 5251-5257.
5. Carpenter, G. (1987). Receptors for epidermal growth factor and other polypeptide mitogens. Annu. Rev. Biochem. 56, 881-914.
6. Carraway, K.L., III, and Cantley, L.C. (1994). A neu acquaintance for erbB3 and erbB4: a role for receptor heterodimerization in growth signaling. Cell 78, 5-8.
7. Chang, C.P., Lazar, C.S., Walsh, B.J., Komuro, M., Collawn, J.F., Kuhn, L.A., Tainer, J.A., Trowbridge, I.S., Farquhar, M.G., and Rosenfeld, M.G. (1993). Ligand-induced internalization of the epidermal growth factor receptor is mediated by multiple endocytic codes analogous to the tyrosine motif found in constitutively internalized receptors. J. Biol. Chem. 268, 19312-19320.
8. Chen, W.S., Lazar, C.S., Lund, K.A., Welsh, J.B., Chang, C.P., Walton, G.M., Der, C.J., Wiley, H.S., Gill, G.N., and Rosenfeld, M.G. (1989). Functional independence of the epidermal growth factor receptor from a domain required for ligand-induced internalization and calcium regulation. Cell 59, 33-43.
9. Chen, W.S., Lazar, C.S., Poenie, M., Tsien, R.Y., Gill, G.N., and Rosenfeld, M.G. (1987). Requirement for intrinsic protein tyrosine kinase in the immediate and late actions of the EGF receptor. Nature 328, 820-823.
10. Coussens, L., Yang-Feng, T.L., Liao, Y.C., Chen, E., Gray, A., McGrath, J., Seeburg, P.H., Libermann, T.A., Schlessinger, J., and Francke, U. (1985). Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location with neu oncogene. Science 230, 1132-1139.
11. Decker, S.J., Alexander, C., and Habib, T. (1992). Epidermal growth factor (EGF)-stimulated tyrosine phosphorylation and EGF receptor degradation in cells expressing EGF receptors truncated at residue 973. J. Biol. Chem. 267, 1104-1108.
12. Di Fiore, P.P., Pierce, J.H., Fleming, T.P., Kazan, R., Ullrich, A., King, C.R., Schlessinger, J., and Aaronson, S.A. (1987). Overexpression of the human EGF receptor confers an EGF-dependent transformed phenotype to NIH 3T3 cells. Cell 51, 1063-1070.
13. Di Guglielmo, G.M., Baass, P.C., Ou, W.J., Posner, B.I., and Bergeron, J.J. (1994). Compartmentalization of SHC, GRB2 and mSOS, and hyperphosphorylation of Raf-1 by EGF but not insulin in liver parenchyma. EMBO J. 13, 4269-4277.
14. Drebin, J.A., Link, V.C., Stern, D.F., Weinberg, R.A., and Greene, M.I. (1985). Down-modulation of an oncogene protein product and reversion of the transformed phenotype by monoclonal antibodies. Cell 41, 697-706.
15. Felder, S., LaVin, J., Ullrich, A., and Schlessinger, J. (1992). Kinetics of binding, endocytosis, and recycling of EGF receptor mutants. J. Cell Biol. 117, 203-212.
16. Felder, S., Miller, K., Moehren, G., Ullrich, A., Schlessinger, J., and Hopkins, C.R. (1990). Kinase activity controls the sorting of the epidermal growth factor receptor within the multivesicular body. Cell 61, 623-634.
17. Gilboa, L., Ben-Levy, R., Yarden, Y., and Henis, Y.I. (1995). Roles for a cytoplasmic tyrosine and tyrosine kinase activity in the interactions of Neu receptors with coated pits. J. Biol. Chem. 270, 7061-7067.
18. Glenney, J.R., Jr., Chen, W.S., Lazar, C.S., Walton, G.M., Zokas, L.M., Rosenfeld, M.G., and Gill, G.N. (1988). Ligand-induced endocytosis of the EGF receptor is blocked by mutational inactivarion and by microinjection of anti-phosphotyrosine antibodies. Cell 52, 675-684.
19. Goldman, R., Levy, R.B., Peles, E., and Yarden, Y. (1990). Heterodimerization of the erbB-1 and erbB-2 receptors in human breast carcinoma cells: a mechanism for receptor transregulation. Biochemistry 29, 11024-11028.
20. Graus-Porta, D., Beerli, R.R., Daly, J.M., and Hynes, N.B. (1997). ErbB-2, the preferred heterodimerization partner of all ErbB receptors, is a mediator of lateral signaling. EMBO J. 16, 1647-1655.
21. Graus-Porta, D., Beerli, R.R., and Hynes, N.E. (1995). Single-chain antibody-mediated intracellular retention of ErbB-2 impairs Neu differentiation factor and epidermal growth factor signaling. Mol. Cell. Biol. 15, 1182-1191.
22. Heldin, C.H. (1995). Dimerization of cell surface receptors in signal transduction. Cell 80, 213-223.
23. Helin, K., and Beguinot, L. (1991). Internalization and down-regulation of the human epidermal growth factor receptor are regulated by the carboxyl-terminal tyrosines. J. Biol. Chem. 266, 8363-8368.
24. Honegger, A.M., Schmidt, A., Ullrich, A., and Schlessinger, J. (1990). Separate endocytic pathways of kinase-defective and -active EGF receptor mutants expressed in same cells. J. Cell Biol. 110, 1541-1548.
25. Honegger, A.M., Szapary, D., Schmidt, A., Lyall, R., Van Obberghen, E., Dull, T.J., Ullrich, A., and Schlessinger, J. (1987). A mutant epidermal growth factor receptor with defective protein tyrosine kinase is unable to stimulate proto-oncogene expression and DNA synthesis. Mol. Cell. Biol. 7, 4568-4571.
26. Hudziak, R.M., Schlessinger, J., and Ullrich, A. (1987). Increased expression of the putative growth factor receptor p185HER2 causes transformation and tumorigenesis of NIH 3T3 cells. Proc. Natl. Acad. Sci. USA 84, 7159-7163.
27. Hurwitz, E., Stancovski, I., Sela, M., and Yarden, Y. (1995). Suppression and promotion of tumor growth by monoclonal antibodies to ErbB-2 differentially correlate with cellular uptake. Proc. Natl. Acad. Sci. USA 92, 3353-3357.
28. Karunagaran, D., Tzahar, E., Beerli, R.R., Chen, X., Graus-Porta, D., Ratzkin, B.J., Seger, R., Hynes, N.E., and Yarden, Y. (1996). ErbB-2 is a common auxiliary subunit of NDF and EGF receptors: implications for breast cancer. EMBO J. 15, 254-264.
29. Klapper, L.N., Vaisman, N., Hurwitz, E., Pinkas-Kramarski, R., Yarden, Y., and Sela, M. (1997). A subclass of tumor-inhibitory monoclonal antibodies to ErbB-2/HER2 blocks cross-talk with growth factor receptors. Oncogene 14, 2099-2109.
30. Koch, C.A., Anderson, D., Moran, M.F., Ellis, C., and Pawson, T. (1991). SH2 and SH3 domains: elements that control interactions of cytoplasmic signaling proteins. Science 252, 668-674.
31. Kraus, M.H., Issing, W., Miki, T., Popescu, N.C., and Aaronson, S.A. (1989). Isolation and characterization of ERBB3, a third member of the ERBB/epidermal growth factor receptor family: evidence for overexpression in a subset of human mammary tumors. Proc. Natl. Acad. Sci. USA 86, 9193-9197.
32. Kraus, M.H., Popescu, N.C., Amsbaugh, S.C., and King, C.R. (1987). Overexpression of the EGF receptor-related proto-oncogene erbB-2 in human mammary tumor cell lines by different molecular mechanisms. EMBO J. 6, 605-610.
33. Miller, S.A., and Hung, M.-C. (1995). Regulation of Her2/neu gene expression (review). Oncol. Rep. 2, 497-503.
34. Moran, M.F., Koch, C.A., Anderson, D., Ellis, C., England, L., Martin, G.S., and Pawson, T. (1990). Src homology region 2 domains direct protein-protein interactions in signal transduction. Proc. Natl. Acad. Sci. USA 87, 8622-8626.
35. Pawson, T. (1995). Protein modules and signaling networks. Nature 373, 573-580.
36. Peles, E., and Yarden, Y. (1993). Neu and its ligands: from an oncogene to neural factors. Bioessays 15, 815-824.
37. Pietras, R.J., Arboleda, J., Reese, D.M., Wongvipat, N., Pegram, M.D., Ramos, L., German, C.M., Parker, M.G., Sliwkowski, M.X., and Slamon, D.J. (1995). HER-2 tyrosine kinase pathway targets estrogen receptor and promotes hormone-independent growth in human breast cancer cells. Oncogene 10, 2435-2446.
38. Pinkas-Kramarski, R., et al. (1996). Diversification of Neu differentiation factor and epidermal growth factor signaling by combinatorial receptor interactions. EMBO J. 15, 2452-2467.
39. Plowman, G.D., Culouscou, J.M., Whitney, G.S., Green, J.M., Carlton, G.W., Foy, L., Neubauer, M.G., and Shoyab, M. (1993). Ligand-specific activation of HER4/p180erbB4, a fourth member of the epidermal growth factor receptor family. Proc. Natl. Acad. Sci. USA 90, 1746-1750.
40. Qian, X., LeVea, C.M., Freeman, J.K., Dougall, W.C., and Greene, M.I. (1994). Heterodimerization of epidermal growth factor receptor and wild-type or kinase-deficient Neu: a mechanism of interreceptor kinase activation and transphosphorylation. Proc. Natl. Acad. Sci. USA 91, 1500-1504.
41. Reese, D.M., and Slamon, D.J. (1997). HER-2/neu signal transduction in human breast and ovarian cancer. Stem Cells 15, 1-8.
42. Schlessinger, J., and Ullrich, A. (1992). Growth factor signaling by receptor tyrosine kinases. Neuron 9, 383-391.
43. Slamon, D.J., Clark, G.M., Wong, S.G., Levin, W.J., Ullrich, A., and McGuire, W.L. (1987). Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 235, 177-182.
44. Slamon, D.J., Godolphin, W., Jones, L.A., Holt, J.A., Wong, S.G., Keith, D.E., Levin, W.J., Stuart, S.G., Udove, J., and Ullrich, A. (1989). Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science 244, 707-712.
45. Sliwkowski, M.X., Schaefer, G., Akita, R.W., Lofgren, J.A., Fitzpatrick, V.D., Nuijens, A., Fendly, B.M., Cerione, R.A., Vandlen, R.L., and Carraway, K.L., III. (1994). Coexpression of erbB2 and erbB3 proteins reconstitutes a high affinity receptor for heregulin. J. Biol. Chem. 269, 14661-14665.
46. Soltoff, S.P., Carraway, K.L., III, Prigent, S.A., Gullick, W.G., and Cantley, L.C. (1994). ErbB3is involved inactivationofphosphatidylinositol 3-kinase by epidermal growth factor. Mol. Cell. Biol. 14, 3550-3558.
47. Sorkin, A., Di Fiore, P.P., and Carpenter, G. (1993). The carboxyl terminus of epidermal growth factor receptor/erbB-2 chimerae is internalization impaired. Oncogene 8, 3021-3028.
48. Sorkin, A., Helin, K., Waters, C.M., Carpenter, G., and Beguinot, L. (1992). Multiple autophosphorylation sites of the epidermal growth factor receptor are essential for receptor kinase activity and internalization. Contrasting significance of tyrosine 992 in the native and truncated receptors. J. Biol. Chem. 267, 8672-8678.
49. Sorkin, A., Waters, C., Overholser, K.A., and Carpenter, G. (1991). Multiple autophosphorylation site mutations of the epidermal growth factor receptor. Analysis of kinase activity and endocytosis. J. Biol. Chem. 266, 8355-8362.
50. Spivak-Kroizman, T., Rotin, D., Pinchasi, D., Ullrich, A., Schlessinger, J., and Lax, I. (1992). Heterodimerization of c-erbB2 with different epidermal growth factor receptor mutants elicits stimulatory or inhibitory responses. J. Biol. Chem. 267, 8056-8063.
51. Stern, D.F., Kamps, M.P., and Cao, H. (1988). Oncogenic activation of p185neu stimulates tyrosine phosphorylation in vivo. Mol. Cell. Biol. 8, 3969-3973.
52. Tzahar, E., Waterman, H., Chen, X., Levkowitz, G., Karunagaran, D., Lavi, S., Ratzkin, B.J., and Yarden, Y. (1996). A hierarchical network of interreceptor interactions determines signal transduction by Neu differentiation factor/neuregulin and epidermal growth factor. Mol. Cell. Biol. 16, 5276-5287.
53. Ullrich, A., Coussens, L., Hayflick, J.S., Dull, T.J., Gray, A., Tam, A.W., Lee, J., Yarden, Y., Libermann, T.A., and Schlessinger, J. (1984). Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells. Nature 309, 418-425.
54. Ullrich, A., and Schlessinger, J. (1990). Signal transduction by receptors with tyrosine kinase activity. Cell 61, 203-212.
55. Vieira, A.V., Lamaze, C., and Schmid, S.L. (1996). Control of EGF receptor signaling by clathrin-mediated endocytosis. Science 274, 2086-2089.
56. Wada, T., Qian, X.L., and Greene, M.I. (1990). Intermolecular association of the p185neu protein and EGF receptor modulates EGF receptor function. Cell 61, 1339-1347.
57. Wang, Z., Gluck, S., Zhang, L., and Moran, M. (1998). Requirement for Phospholipase C-gammal enzymatic activity in growth factor-induced mitogenesis. Mol. Cell. Biol. 18, 590-597.
58. Wang, Z., and Moran, M.F. (1996). Requirement for the adapter protein GRB2 in EGF receptor endocytosis. Science 272, 1935-1939.
59. Wang, Z., Tung, P.S., and Moran, M.F. (1996). Association of p120 ras GAP with endocytic components and colocalization with epidermal growth factor (EGF) receptor in response to EGF stimulation. Cell Growth & Differ. 7, 123-133.
60. Weiner, D.B., Liu, J., Cohen, J.A., Williams, W.V., and Greene, M.I. (1989). A point mutation in the neu oncogene mimics ligand induction of receptor aggregation. Nature 339, 230-231.
61. Wells, A., Welsh, J.B., Lazar, C.S., Wiley, H.S., Gill, G.N., and Rosenfeld, M.G. (1990). Ligand-induced transformation by a noninternalizing epidermal growth factor receptor. Science 247, 962-964.
62. Wiley, H.S., Herbst, J.J., Walsh, B.J., Lauffenburger, D.A., Rosenfeld, M.G., and Gill, G.N. (1991). The role of tyrosine kinase activity in endocytosis, compartmentation, and down-regulation of the epidermal growth factor receptor. J. Biol. Chem. 266, 11083-11094.
63. Worthylake, R., and Wiley, H.S. (1997). Structural aspects of the epidermal growth factor receptor required for transmodulation of erbB2/neu. J. Biol. Chem. 272, 8594-8601.
64. Yamamoto, T., Ikawa, S., Akiyama, T., Nomura, N., Miyajima, N., Saito, T., and Toyoshima, K. (1986). Similarity of protein encoded by the human c-erb-B-2 gene to epidermal growth factor receptor. Nature 319, 230-234.
65. Yarden, Y., and Schlessinger, J. (1987). Self-phosphorylation of epidermal growth factor receptor: evidence for a model of intermolecular allosteric activation. Biochemistry 26, 1434-1442.